Published in Mayo Clin Proc on June 01, 2002
What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D. Health Qual Life Outcomes (2003) 3.42
Responsiveness and minimal important differences for patient reported outcomes. Health Qual Life Outcomes (2006) 2.48
Patient-reported outcomes in randomized clinical trials: development of ISOQOL reporting standards. Qual Life Res (2012) 1.62
The clinical significance of quality of life assessments in oncology: a summary for clinicians. Support Care Cancer (2006) 1.47
Measuring changes in functional status among patients with schizophrenia: the link with cognitive impairment. Schizophr Bull (2006) 1.06
A short functional survey is responsive to changes in functional status in vulnerable older people. J Am Geriatr Soc (2008) 1.02
Association of complementary methods with quality of life and life satisfaction in patients with gynecologic and breast malignancies. Support Care Cancer (2007) 1.01
Time to deterioration in quality of life score as a modality of longitudinal analysis in patients with breast cancer. Oncologist (2011) 0.97
Health-related quality of life as an outcome variable in Parkinson's disease. Ther Adv Neurol Disord (2012) 0.92
Symptom burden among patients with renal cell carcinoma (RCC): content for a symptom index. Health Qual Life Outcomes (2007) 0.91
The measurement of response shift in patients with advanced prostate cancer and their partners. Health Qual Life Outcomes (2005) 0.91
Psychometric characteristics of the Spanish version of instruments to measure neck pain disability. BMC Musculoskelet Disord (2008) 0.86
Relation between severe illness and non-completion of quality-of-life questionnaires by patients with rectal cancer. J R Soc Med (2003) 0.85
Response shift due to diagnosis and primary treatment of localized prostate cancer: a then-test and a vignette study. Qual Life Res (2007) 0.84
Patient rated outcomes and survivorship following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (CS + HIPEC). J Surg Oncol (2012) 0.80
Effect of store and forward teledermatology on quality of life: a randomized controlled trial. JAMA Dermatol (2013) 0.79
Approaches and methodological as well as interpretative issues in quality of life research in malaysia. Malays J Med Sci (2003) 0.78
Reporting on quality of life in randomised controlled trials in gastrointestinal surgery. J Gastrointest Surg (2009) 0.75
Placing quality of life assessments on oncologists' agenda. Support Care Cancer (2006) 0.75
Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-Reported Outcomes Measurement Information System (PROMIS). Med Care (2007) 12.71
Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res (2002) 9.99
Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain (2007) 8.89
Methods to explain the clinical significance of health status measures. Mayo Clin Proc (2002) 7.00
The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol (2010) 6.61
Erectile dysfunction and subsequent cardiovascular disease. JAMA (2005) 6.22
Intermittent versus continuous androgen deprivation in prostate cancer. N Engl J Med (2013) 6.17
The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res (2010) 6.09
Treating depression in predominantly low-income young minority women: a randomized controlled trial. JAMA (2003) 5.28
Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension. JAMA (2013) 4.98
Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items. Qual Life Res (2009) 4.13
The COSMIN checklist for evaluating the methodological quality of studies on measurement properties: a clarification of its content. BMC Med Res Methodol (2010) 4.10
Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report. Value Health (2008) 3.68
Family satisfaction with family conferences about end-of-life care in the intensive care unit: increased proportion of family speech is associated with increased satisfaction. Crit Care Med (2004) 3.18
The Rapid Assessment of Physical Activity (RAPA) among older adults. Prev Chronic Dis (2006) 3.12
Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J Natl Cancer Inst (2005) 2.99
The use of patient-reported outcomes instruments in registered clinical trials: evidence from ClinicalTrials.gov. Contemp Clin Trials (2009) 2.88
Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study. Clin Gastroenterol Hepatol (2005) 2.68
Malignant primary cardiac tumors: review of a single institution experience. Cancer (2008) 2.59
Estimating clinically significant differences in quality of life outcomes. Qual Life Res (2005) 2.55
Assessment of community functioning in people with schizophrenia and other severe mental illnesses: a white paper based on an NIMH-sponsored workshop. Schizophr Bull (2006) 2.53
Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire (SF-MPQ-2). Pain (2009) 2.53
A measure of the quality of dying and death. Initial validation using after-death interviews with family members. J Pain Symptom Manage (2002) 2.33
Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): a randomised phase 3 trial. Lancet Oncol (2013) 2.29
Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patients. Hepatology (2002) 2.27
Late cardiac effects of adjuvant chemotherapy in breast cancer survivors treated on Southwest Oncology Group protocol s8897. J Clin Oncol (2008) 2.26
Barriers and facilitators to end-of-life care communication for patients with COPD. Chest (2005) 2.23
Validation of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) in age-related macular degeneration. Invest Ophthalmol Vis Sci (2011) 2.23
Dissatisfaction with medical services among Medicare beneficiaries with disabilities. Arch Phys Med Rehabil (2002) 1.99
ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research. Qual Life Res (2013) 1.96
Assessing the clinical significance of single items relative to summated scores. Mayo Clin Proc (2002) 1.93
Studying communication about end-of-life care during the ICU family conference: development of a framework. J Crit Care (2002) 1.90
Assessing symptoms in gastroesophageal reflux disease: how well do clinicians' assessments agree with those of their patients? Am J Gastroenterol (2005) 1.87
Pediatric patient-reported outcome instruments for research to support medical product labeling: report of the ISPOR PRO good research practices for the assessment of children and adolescents task force. Value Health (2013) 1.87
Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial. Obstet Gynecol (2010) 1.85
The use of patient-reported outcomes (PRO) within comparative effectiveness research: implications for clinical practice and health care policy. Med Care (2012) 1.84
Patient-reported outcomes assessment in cancer trials: taking stock, moving forward. J Clin Oncol (2007) 1.84
Evaluation of the methodological quality of systematic reviews of health status measurement instruments. Qual Life Res (2009) 1.82
Efficacy of complementary and alternative medicine therapies in relieving cancer pain: a systematic review. J Clin Oncol (2006) 1.82
Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy. J Clin Oncol (2013) 1.81
Premature ejaculation: results from a five-country European observational study. Eur Urol (2007) 1.79
Economic analysis of vinorelbine plus cisplatin versus paclitaxel plus carboplatin for advanced non-small-cell lung cancer. J Natl Cancer Inst (2002) 1.78
Association of depression and life-sustaining treatment preferences in patients with COPD. Chest (2005) 1.77
The German version of the Oral Health Impact Profile--translation and psychometric properties. Eur J Oral Sci (2002) 1.76
Vision-specific instruments for the assessment of health-related quality of life and visual functioning: a literature review. Pharmacoeconomics (2002) 1.75
A structured review of randomized controlled trials of weight loss showed little improvement in health-related quality of life. J Clin Epidemiol (2005) 1.71
Glutamine does not prevent paclitaxel-associated myalgias and arthralgias. J Support Oncol (2004) 1.66
Individual differences in quality-of-life treatment response. Med Care (2002) 1.64
Oncologic emergencies: diagnosis and treatment. Mayo Clin Proc (2006) 1.60
Adalimumab treatment is associated with improvement in health-related quality of life in psoriasis: patient-reported outcomes from a phase II randomized controlled trial. J Dermatolog Treat (2007) 1.60
Quality of dying and death in two medical ICUs: perceptions of family and clinicians. Chest (2005) 1.53
The mathematical relationship among different forms of responsiveness coefficients. Qual Life Res (2007) 1.53
Prevalence of secondary conditions among people with disabilities. Am J Public Health (2004) 1.52
Longitudinal analysis of sexual function reported by men in the Prostate Cancer Prevention Trial. J Natl Cancer Inst (2007) 1.52
The impact of urinary urgency and frequency on health-related quality of life in overactive bladder: results from a national community survey. Value Health (2004) 1.52
Depression with atypical features in the National Comorbidity Survey: classification, description, and consequences. Arch Gen Psychiatry (2003) 1.50
Inter-rater agreement and reliability of the COSMIN (COnsensus-based Standards for the selection of health status Measurement Instruments) checklist. BMC Med Res Methodol (2010) 1.50
Is a family equal to the sum of its parts? Estimating family-level well-being for cost-effectiveness analysis. Qual Life Res (2005) 1.49
Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group Study 9626. J Clin Oncol (2008) 1.49
Adolescent quality of life, part I: conceptual and measurement model. J Adolesc (2002) 1.48
An educational program to increase cervical and breast cancer screening in Hispanic women: a Southwest Oncology Group study. Cancer Nurs (2005) 1.48
Patient income level and cancer clinical trial participation. J Clin Oncol (2013) 1.48
The clinical significance of quality of life assessments in oncology: a summary for clinicians. Support Care Cancer (2006) 1.47
Characterization of health related quality of life (HRQOL) for patients with functional bowel disorder (FBD) and its response to treatment. Am J Gastroenterol (2007) 1.44
Trajectories of health for older adults over time: accounting fully for death. Ann Intern Med (2003) 1.44
Assessing clinical significance in measuring oncology patient quality of life: introduction to the symposium, content overview, and definition of terms. Mayo Clin Proc (2002) 1.44
Precision of health-related quality-of-life data compared with other clinical measures. Mayo Clin Proc (2007) 1.43
Commentary on "Critical flaws in the FSFI and IIEF". J Sex Res (2014) 1.40
Quality of life and pain in advanced stage prostate cancer: results of a Southwest Oncology Group randomized trial comparing docetaxel and estramustine to mitoxantrone and prednisone. J Clin Oncol (2006) 1.38
Group vs individual approaches to understanding the clinical significance of differences or changes in quality of life. Mayo Clin Proc (2002) 1.37
Systematic review and meta-analysis of exercise tolerance and physical functioning in dialysis patients treated with erythropoiesis-stimulating agents. Am J Kidney Dis (2010) 1.36
Managed care and primary physician satisfaction. J Am Board Fam Pract (2003) 1.31
The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study. Health Qual Life Outcomes (2006) 1.31
Depressive symptoms and mortality in a prospective study of 2,558 older adults. Am J Geriatr Psychiatry (2002) 1.31
Validation of electronic data capture of the Irritable Bowel Syndrome--Quality of Life Measure, the Work Productivity and Activity Impairment Questionnaire for Irritable Bowel Syndrome and the EuroQol. Value Health (2006) 1.29
A model for incorporating patient and stakeholder voices in a learning health care network: Washington State's Comparative Effectiveness Research Translation Network. J Clin Epidemiol (2013) 1.28
The role of technical advances in the adoption and integration of patient-reported outcomes in clinical care. Med Care (2015) 1.28
Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a consensus statement. J Clin Psychiatry (2010) 1.27
Managed care, access to mental health specialists, and outcomes among primary care patients with depressive symptoms. J Gen Intern Med (2002) 1.27
Cross-cultural development and validation of a patient self-administered questionnaire to assess quality of life in upper gastrointestinal disorders: the PAGI-QOL. Qual Life Res (2004) 1.26
The link between health-related quality of life and clinical symptoms among children with attention-deficit hyperactivity disorder. J Dev Behav Pediatr (2004) 1.26
Methods for incorporating death into health-related variables in longitudinal studies. J Clin Epidemiol (2005) 1.26
Validation of the EQ-5D in a general population sample in urban China. Qual Life Res (2011) 1.25
Linking pain items from two studies onto a common scale using item response theory. J Pain Symptom Manage (2009) 1.25
Preliminary treatment considerations among men with newly diagnosed prostate cancer. Am J Manag Care (2010) 1.24
Exploration of the value of health-related quality-of-life information from clinical research and into clinical practice. Mayo Clin Proc (2007) 1.24
Managed care and the US health care system a social exchange perspective. Soc Sci Med (2002) 1.24
Managed care, physician job satisfaction, and the quality of primary care. J Gen Intern Med (2005) 1.21
Health behaviors of employed and insured adults in the United States, 2004-2005. Am J Health Promot (2010) 1.21
Oncologic emergencies: Pathophysiology, presentation, diagnosis, and treatment. CA Cancer J Clin (2011) 1.20
Quality of life of women with urinary incontinence: cross-cultural performance of 15 language versions of the I-QOL. Qual Life Res (2005) 1.19
The impact of diabetic retinopathy: perspectives from patient focus groups. Fam Pract (2004) 1.18